Business Description
Founded in Beijing in 2015, Jacobio Pharmaceuticals is a China-based drug discovery company focused entirely on developing new cancer treatments. The company has built a broad pipeline of experimental therapies targeting some of the most difficult-to-treat cancers, including lung, pancreatic, and colorectal tumors, with several candidates already in advanced clinical trials. Jacobio also works alongside Merck to explore combination treatment approaches, strengthening its position as a serious player in the global oncology space.
